Search

Search Results
Results 1361 - 1370 of 1414 for Active treatment
  • Somidem
    Drug - 29 Feb 2024
    Consumer Medicine Information (CMI) about Somidem intended for persons living in Australia.
  • Sugammadex Viatris
    Drug - 30 Jan 2024
    Consumer Medicine Information (CMI) about Sugammadex Viatris intended for persons living in Australia.
  • Hydrocortisone Viatris 4 and 20 (formerly Hydrocortisone Mylan)
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Hydrocortisone Viatris 4 and 20 intended for persons living in Australia.
  • Rhinocort Hayfever and Allergy Original
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Rhinocort Hayfever (Budesonide) intended for persons living in Australia.
  • IPOL
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about IPOL intended for persons living in Australia.
  • Codral Dry Cough and Cold with Antihistamine
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Codral Dry Cough and Cold with Antihistamine intended for persons living in Australia.
  • Benadryl Original Oral Liquid (New Formula)
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Benadryl Original Oral Liquid (New Formula) intended for persons living in Australia.
  • Trental
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Trental intended for persons living in Australia.
  • Duromine
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Duromine intended for persons living in Australia.
  • Incruse Ellipta
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Incruse Ellipta intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback